title: Guidelines on oral anticoagulation with warfarin - fourth edition.
authors.affiliation: Oxford Radcliffe Hospitals, Oxford, UK. majha001@umn.edu
authors.forename: David
authors.initials: D
authors.lastname: Keeling
authors.forename: Trevor
authors.initials: T
authors.lastname: Baglin
authors.forename: Campbell
authors.initials: C
authors.lastname: Tait
authors.forename: Henry
authors.initials: H
authors.lastname: Watson
authors.forename: David
authors.initials: D
authors.lastname: Perry
authors.forename: Caroline
authors.initials: C
authors.lastname: Baglin
authors.forename: Steve
authors.initials: S
authors.lastname: Kitchen
authors.forename: Michael
authors.initials: M
authors.lastname: Makris
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006259:Craniocerebral Trauma / Q000150:complications; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods; D006470:Hemorrhage / Q000139:chemically induced / Q000628:therapy; D006801:Humans; D019934:International Normalized Ratio; D019990:Perioperative Care / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000517:prevention & control; D020246:Venous Thrombosis / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin